Related Experiment Video
Updated: Mar 8, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
Published on: January 12, 2017
Prostate-specific Antigen Levels in Moroccan Diabetic Males: A Cross-sectional Study
Abdelhakim Ainahi1, Abdelhamid Brakat2, Lahcen Wakrim3
1Hormonology and Tumor Markers Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
Background:
Recent studies have shown an inverse relationship between diabetes and prostate- specific antigen (PSA) levels.
Objective:
This study aimed to evaluate the PSA levels in the serum of diabetic and non-diabetic Moroccan males.
Methods:
In a cross-sectional study, four hundred and seventy diabetic and 869 non-diabetic males were screened from January 2015 to April 2016 at Pasteur institute of Morocco. Hemoglobin A1c and Fasting Blood Glucose were measured using high performance liquid chromatography and dry chemistry, respectively. We used a chemiluminescent microparticle immunoassay technology to evaluate the levels of Serum PSA and testosterone.
Results:
Overall, the PSA levels revealed no significant difference between diabetic and non-diabetic males (1.31 ± 0.04ng/mL vs.1.36 ± 0.03ng/mL, p = 0.380, respectively). The PSA levels increased with age both in non-diabetics and diabetics. Moreover, in diabetic subjects, the PSA levels were less age dependent (p =0.002) than in non-diabetic (p < 0.0001). The stratified analysis showed that the PSA was significantly lower in diabetic than in non-diabetic subjects aged between 50-59 years (p= 0.0004). Furthermore, no significant testosterone concentrations were observed in the subjects with or without diabetes (p= 0.904).
Conclusion:
Our results show that the PSA levels are age-dependant in diabetic and non-diabetic males but the PSA levels are affected by diabetes status only in the group aged between 50-59 years.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024